214 related articles for article (PubMed ID: 29438213)
1. New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
Abid S; Kebe K; Houssaïni A; Tomberli F; Marcos E; Bizard E; Breau M; Parpaleix A; Tissot CM; Maitre B; Lipskaia L; Derumeaux G; Bastia E; Mekontso-Dessap A; Adnot S
J Cardiovasc Pharmacol; 2018 May; 71(5):283-292. PubMed ID: 29438213
[TBL] [Abstract][Full Text] [Related]
2. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vasodilation by phosphodiesterase 5 inhibition is enhanced and nitric oxide independent in early pulmonary hypertension after myocardial infarction.
van Duin RWB; Houweling B; Uitterdijk A; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H170-H179. PubMed ID: 28986358
[TBL] [Abstract][Full Text] [Related]
4. Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.
Alvarez RA; Miller MP; Hahn SA; Galley JC; Bauer E; Bachman T; Hu J; Sembrat J; Goncharov D; Mora AL; Rojas M; Goncharova E; Straub AC
Am J Respir Cell Mol Biol; 2017 Dec; 57(6):733-744. PubMed ID: 28800253
[TBL] [Abstract][Full Text] [Related]
5. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
6. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
7. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha.
Pekarova M; Koudelka A; Kolarova H; Ambrozova G; Klinke A; Cerna A; Kadlec J; Trundova M; Sindlerova Svihalkova L; Kuchta R; Kuchtova Z; Lojek A; Kubala L
Vascul Pharmacol; 2015 Oct; 73():138-48. PubMed ID: 26091577
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrobiopterin (BH
Francis BN; Salameh M; Khamisy-Farah R; Farah R
Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29151278
[TBL] [Abstract][Full Text] [Related]
11. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
[TBL] [Abstract][Full Text] [Related]
12. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
Zhou Y; Tian X; Wang X; Wang Y; Fan R; Wang Y; Feng N; Zhang S; Guo H; Gu X; Jia M; Yin W; Hou Z; Li J; Pei J
Eur J Pharmacol; 2018 Aug; 832():129-137. PubMed ID: 29782857
[TBL] [Abstract][Full Text] [Related]
13. Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.
Siciliano A; Malpeli G; Platt OS; Lebouef C; Janin A; Scarpa A; Olivieri O; Amato E; Corrocher R; Beuzard Y; De Franceschi L
Haematologica; 2011 Jan; 96(1):24-32. PubMed ID: 20851863
[TBL] [Abstract][Full Text] [Related]
14. Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation.
Sopko NA; Matsui H; Hannan JL; Berkowitz D; Champion HC; Hsu LL; Musicki B; Burnett AL; Bivalacqua TJ
J Sex Med; 2015 Sep; 12(9):1878-85. PubMed ID: 26346631
[TBL] [Abstract][Full Text] [Related]
15. A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
Mohamed NA; Ahmetaj-Shala B; Duluc L; Mackenzie LS; Kirkby NS; Reed DM; Lickiss PD; Davies RP; Freeman GR; Wojciak-Stothard B; Chester AH; El-Sherbiny IM; Mitchell JA; Yacoub MH
J Cardiovasc Transl Res; 2016 Apr; 9(2):162-4. PubMed ID: 26960567
[TBL] [Abstract][Full Text] [Related]
16. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
[TBL] [Abstract][Full Text] [Related]
18. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
19. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
Kaul DK; Zhang X; Dasgupta T; Fabry ME
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H39-47. PubMed ID: 18456737
[TBL] [Abstract][Full Text] [Related]
20. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
